Advanced gastrointestinal stromal tumor patients with complete response after treatment with imatinib mesylate

AIM: Most gastrointestinal stromal tumors (GISTs) express constitutively activated mutant isoforms of kit kinase or platelet-derived growth factor receptor alpha (PDGFRA), which are potential therapeutic targets for imatinib mesylate (Glivec). Partial response occurred in almost two thirds of GIST p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chiang, Kun-Chun, Chen, Tsung-Wen, Yeh, Chun-Nan, Liu, Feng-Yuan, Lee, Hsiang-Lin, Jan, Yi-Yin
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Co., Limited 2006
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4087685/
https://ncbi.nlm.nih.gov/pubmed/16610057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i13.2060
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars